Corporate
Profile
Failed to register as Favorite Page
Failed to cancel as Favorite Page
This page is already registered as a Favorite Page
You can't add your company to your favorites.
Latest update： 25/02/2022 13:37:49
Oligogen, Inc.
By using stem cell technology to establish new treatment methods for the central nervous system diseases, we improve patient’s quality of life and reduce the burden on their families
We are a bio venture company attempting to overcome central nervous system diseases, which have limited methods of treatment. Using platform technology with the neural stem cell “OligoGenie” at its core, we intend to deliver new treatment methods for neurological diseases which have no effective treatment methods developed so far. We have already had a patent for the culture method of “OligoGenie” and collected cells (Patent No. 5649745), and have obtained patents in Japan and about 30 other countries around the world.
Overview
| Corporate name | Oligogen, Inc. |
|---|---|
| Representative | Tsuneo Kido |
| Corporate website | https://www.oligogen.jp/ |
| Capital | 98,000,000 Yen |
| Number of Employees | 2 (Number of full-time employees: 2) |
| Established date | 08, 2015 |
| Head office: Country | Japan |
| Head office: Address | Kyoto University. 46-29 Yoshida Shimoadachicho, Sakyo-ku, Kyoto-shi,, Kyoto Prefecture, 606-8501 |
| Industry | Miscellaneous manufacturing industries |
Client & Business location info
| Support organization | Organization for Small & Medium Enterprises and Regional Innovation, JAPAN, Marketing Support Department |
|---|
